2024 Advertising Rates

DISTRIBUTION

Every month CAP TODAY brings essential news to all key decision makers—clinical lab managers and administrators, pathologists, physicians, lab directors, and supervisory technologists responsible for clinical laboratory purchases.

This news includes advances in tests and equipment, trends in management and clinical operation, regulatory changes, and finance, plus news about the laboratory improvement programs of the College of American Pathologists.

READERS: 40,000

All key decision-makers, no excess

• Pathologists and Laboratory Directors: 18,000
• Laboratory Managers and Laboratory Administrators: 6,000
• Chief Techs; Section Managers/Supervisors of Chemistry, Hematology, Microbiology, Immunology, Blood Bank, Cytology, or Histotechnology: 16,000

SERVICES TO ADVERTISERS

AD-MARK In 2024, CAP TODAY will test all ads in the February, July, and November issues.

This service provides feedback from readers as to how an ad is received. Companies can track how an ad stacks up to others, evaluate the effectiveness of an ad that has been running, and perform valuable benchmarking for new campaigns. Ask your representative for details.

Readex Ad Impact Study September 2024 issue.

The Readex Ad Impact Study examines multiple facets of readers’ attitudes to ads—includes verbatim comments and measures of attention, appeal, and reading.

PROVEN RESEARCH

Independent research studies show that CAP TODAY is #1 in total ad exposures for the marketplace.

Kantar Media Healthcare Research has completed new studies on pathologists, clinical lab directors, lab managers and administrators, section managers and supervisors, and total hospital purchasing influence. CAP TODAY carries more advertising than any other book in the field.